Paul Hunter of Foley
12 August 2025FeaturesAmericasPaul Hunter

Why Trump’s revenue-raising patent plan is riddled with problems

A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
11 August 2025   Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.

More on this story

Americas
11 August 2025   Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.

More on this story

Americas
11 August 2025   Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.